Qube Research & Technologies (QRT)
DGX icon

Qube Research & Technologies (QRT)’s Quest Diagnostics DGX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$144M Buy
734,714
+1,258
+0.2% +$244K 0.16% 138
2025
Q4 		$127M Buy
733,456
+203,656
+38% +$37.1M 0.13% 175
2025
Q3 		$101M Buy
529,800
+112,267
+27% +$19.9M 0.1% 237
2025
Q2 		$75M Sell
417,533
-19,813
-5% -$3.44M 0.08% 332
2025
Q1 		$74M Sell
437,346
-11,206
-2% -$1.84M 0.09% 292
2024
Q4 		$67.7M Buy
448,552
+312,001
+228% +$48.5M 0.09% 282
2024
Q3 		$21.2M Buy
136,551
+136,548
+4,551,600% +$20.4M 0.03% 647
2024
Q2 		$411 Sell
3
-191,906
-100% -$26.3M ﹤0.01% 3326
2024
Q1 		$25.5M Buy
191,909
+187,430
+4,185% +$24.3M 0.04% 487
2023
Q4 		$618K Sell
4,479
-138,917
-97% -$18.3M ﹤0.01% 2174
2023
Q3 		$17.5M Buy
+143,396
New +$19.1M 0.05% 450
2023
Q2 		– Sell
-10,150
Closed -$1.44M – 2515
2023
Q1 		$1.44M Buy
+10,150
New +$1.45M 0.01% 1148
2022
Q3 		– Sell
-2,151
Closed -$286K – 2587
2022
Q2 		$286K Buy
+2,151
New +$293K ﹤0.01% 1608
2021
Q4 		– Sell
-131,526
Closed -$19.1M – 2609
2021
Q3 		$19.1M Buy
131,526
+69,325
+111% +$10.1M 0.24% 88
2021
Q2 		$8.21M Buy
62,201
+20,732
+50% +$2.71M 0.09% 259
2021
Q1 		$5.32M Sell
41,469
-36,072
-47% -$4.44M 0.08% 307
2020
Q4 		$9.24M Buy
+77,541
New +$9.45M 0.13% 165
2020
Q3 		– Sell
-10,188
Closed -$1.16M – 1761
2020
Q2 		$1.16M Sell
10,188
-42,305
-81% -$4.49M 0.02% 809
2020
Q1 		$4.21M Buy
52,493
+32,803
+167% +$3.4M 0.17% 114
2019
Q4 		$2.1M Buy
+19,690
New +$2.05M 0.07% 350
2019
Q2 		– Sell
-4,639
Closed -$417K – 434
2019
Q1 		$417K Buy
+4,639
New +$402K 0.06% 346
2018
Q4 		– Sell
-1,593
Closed -$172K – 451
2018
Q3 		$172K Buy
1,593
+1,170
+277% +$128K 0.02% 559
2018
Q2 		$47K Sell
423
-201
-32% -$20.9K 0.03% 541
2018
Q1 		$62K Buy
+624
New +$63.9K 0.02% 261

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Qube Research & Technologies (QRT)'s DGX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Quest Diagnostics (DGX) stake by 0.17% in Q1 2026, buying an estimated $244K and bringing the position to 734,714 shares worth $144M. The position accounts for 0.16% of the portfolio, ranked #138.

Qube Research & Technologies (QRT) first reported a position in DGX in Q1 2018 and has held it in 24 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Qube Research & Technologies (QRT) held 734,714 shares of Quest Diagnostics worth $144M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 1,258 Quest Diagnostics shares in Q1 2026, an estimated $244K.
  • Quest Diagnostics made up 0.16% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #138 holding.
  • Qube Research & Technologies (QRT) first reported a position in Quest Diagnostics in Q1 2018 and has held it in 24 quarters since.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.